A U.S. expert panel rejected it last June because of fears it might trigger suicidal thoughts. 머크사를 포함한 다른 제약회사들도 유사한 약물을 개발하고 있습니다. Bears team at MIT was hoping to gain insight into how the brain adapts and rewires itself through learned experiences.